Cover Image
市場調查報告書

全球治療用疫苗市場:趨勢及預測

Global Therapeutic Vaccines Market- Trends And Forecasts (2016-2021)

出版商 Mordor Intelligence LLP 商品編碼 319400
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球治療用疫苗市場:趨勢及預測 Global Therapeutic Vaccines Market- Trends And Forecasts (2016-2021)
出版日期: 2016年01月01日 內容資訊: 英文
簡介

疫苗市場雖然在全球醫藥品市場的銷售額僅佔2∼3%,不過,近幾年急速發展,從2000年的50億美元到2013年擴大到240億美元。預計今後至2020年也會以12.4%的年複合成長率擴大。

本報告提供全球治療用疫苗市場趨勢與疫苗概要、各用途、各地區趨勢、主要的參與企業的競爭環境與簡介等彙整資料。

第1章 簡介

第2章 摘要整理

第3章 全球治療性蛋白質市場:產業分析

  • 市場的推動要素
    • 需求擴大、發病率的上升
    • 政府支援的計劃和援助
    • 盈利高及技術改良
  • 市場機會
    • 成為新目標的人口:從已開發國家轉移到發展中國家
  • 阻礙市場的要素
  • 壞影響風險

第4章 疫苗的種類

  • 活病毒疫苗、弱毒化疫苗
  • 不活化疫苗
  • 次單元疫苗
  • 類毒素疫苗
  • 共軛疫苗
  • DNA疫苗
  • 重組載體疫苗

第5章 各用途疫苗市場(市場規模、預測、年複合成長率)

  • 兒童用疫苗
  • 成人用疫苗

第6章 疫苗市場的各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 競爭環境

  • 疫苗相關目前市場趨勢
  • 疫苗的未來
  • 合資企業
  • 合併、收購
  • PenAct HIB、Quinvaxem、5價疫苗的未來

第8章 企業簡介

  • Sanofi Avnetis
  • Merck
  • Glaxosmithkline
  • Novartis
  • Pfizer
  • Serum institute

第9章 表格清單

第10章 圖表清單

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The Global market for Therapeutic vaccines is expected to reach $4.82 billion by the end of 2020 growing at a CAGR of around 33.6% from $ 1.15 Billion in 2015. Several new approaches are being developed in order to boost the immune response to the cancerous cells.These technical advancements are expected to add powerful new components to the standard cancer treatments.In the pipeline, therapeutic vaccines are also in development to treat infectious diseases such as the Human Immunodeficiency Virus (HIV), neurological disorders such as Alzheimers disease, autoimmune disorders such as rheumatoid arthritis and multiple sclerosis, and other conditions such as hypertension.

The Global Therapeutic Vaccines Market is segregated on the basis of Autoimmune Disease Vaccines (Type I Diabetes), Neurological Disease Vaccines (CAD106, ACC-001, Alzheimer's Disease, Parkinsons Disease Vaccine and Other Disease Vaccines), Cancer Vaccines (TroVax, PR1 Peptide Vaccine, Multikine, CYT004-MelQbG10 etc..), and Infectious Disease Vaccines (HIV/AIDS, Hepatitis C, and Other Infectious Disease Vaccines) & Region (North America, Europe, Asia Pacific & Rest of the World).

Drivers

The Favorable government funding for vaccine development, increasing investments by the companies Technological advancements, rising prevalence of disease are the major factors that are driving the market growth.

Challenges

Huge capital expenditures and Stringent Regulatory policies are hindering the market growth.

What the report offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the Global Therapeutic vaccines Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

Identification and analysis of the Macro and Micro factors that affect the Global Therapeutic vaccines Market in Healthcare Industry on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

  • Introduction
  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period years
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions
  • Executive Summary
  • Key Inferences
  • Market Overview and Industry trends
  • Current Market Senario
  • Newborn Screening test Applications
  • Technology Overview
  • New Developments
  • Industry Value chain analysis
  • product Life cycle analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat to new entrants
  • Threat to substitute products and services
  • Competitive Rivalry within the industry
  • Drivers, Restraints, Opportunities, and challenges Analysis
  • Market Drivers
  • Favorable government funding for vaccine development
  • Increasing investments by the companies
  • Technological advancements
  • Rising Prevalences of Disease
  • Market Restraints
  • Huge capital expenditures
  • Stringent Regulatory Polices
  • Global Therapeutic Vaccines Market segmentation
  • Introduction
  • Segmentation by product type
  • Autoimmune Disease Vaccines
  • Tovaxin
  • Diamyd( rhGAD65)
  • BHT-3021
  • Neurological Disease Vaccines
  • CAD106
  • ACC-001
  • Alzhiemer's Disease
  • Parkinson's Disease
  • Others
  • Cancer Vaccines
  • TroVax
  • PR1 Peptide Vaccine
  • Multikine
  • CYT004-MelQbG10
  • BLP25 Liposome vaccine
  • HyperAcute Melanoma
  • Provenge (APC8015, Sipuleucel-T)
  • Allovectin-7
  • GRNVAC1
  • ProstVac
  • Belagenpumatucel-L (Lucanix)
  • GSK1572932A
  • MelCancerVac
  • Abagovomab
  • DCVax-Brain
  • JX-594
  • GSK2132231A
  • "GI-4000
  • "
  • HyperAcute-Pancreas
  • TG4001/R3484 (MVA-HPV-IL2)
  • HyperAcute-Lung
  • PEP223
  • AGS-003
  • Glionix
  • AE37
  • NeuVax (E75)
  • "Onyvax-P (ONY-P1)
  • "
  • TG4010 (MVA-MUC1-IL2)
  • CDX-110 (PF-04948568)
  • GV1001
  • CB-10-01
  • MyVax
  • Biovaxid
  • Infectious Disease Vaccine
  • HIV/AIDS
  • Hepatitis C
  • Others
  • Market segmentation by Geography
  • North America
  • Introduction
  • United States
  • Canada
  • Mexico
  • Europe
  • Introduction
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Scandinavia
  • BENELUX
  • Rest of Europe
  • Asia-Pacific (APAC)
  • Introduction
  • China
  • Japan
  • India
  • Australia and New Zealand
  • South Korea
  • Rest of Asia Pacific
  • Middle-East and North Africa
  • Introduction
  • GCC
  • Egypt
  • Morocco
  • Algeria
  • South Africa
  • Rest of Middle-east & Africa
  • South America
  • Introduction
  • Brazil
  • Argentina
  • Rest of Latin America
  • Competitive Landscape
  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Parterships
  • Key Vendor Analysis
  • Antigenics
  • Bavarian Nordic
  • Celtic Pharma
  • Curevac
  • Cytos Biotechnology
  • GlaxoSmithKline
  • Pfizer
  • Merck Kgaa (Merck Serono)
  • Novartis
  • Transgene
  • Vaccinogen
  • Others
  • Analyst outlook for Investment opportunities
  • Future Outlook of the market
Back to Top